Menu
Back to User profile » Dr Chonlaphat Sukasem
Papers published by Dr Chonlaphat Sukasem:
Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV
Turongkaravee S, Praditsitthikorn N, Ngamprasertchai T, Jittikoon J, Mahasirimongkol S, Sukasem C, Udomsinprasert W, Wu O, Chaikledkaew U
ClinicoEconomics and Outcomes Research 2022, 14:447-463
Published Date: 7 July 2022
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
Vanwong N, Tipnoppanon S, Na Nakorn C, Srisawasdi P, Rodcharoen P, Medhasi S, Chariyavilaskul P, Siwamogsatham S, Vorasettakarnkij Y, Sukasem C
Pharmacogenomics and Personalized Medicine 2022, 15:119-130
Published Date: 17 February 2022
Influence of SULT1A1*2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients
Chamnanphon M, Sukprasong R, Gaedigk A, Manosuthi W, Chariyavilaskul P, Wittayalertpanya S, Koomdee N, Jantararoungtong T, Puangpetch A, Sukasem C
Pharmacogenomics and Personalized Medicine 2021, 14:915-926
Published Date: 24 July 2021
A Novel Allele-Specific PCR Protocol for the Detection of the HLA-C*03:02 Allele, a Pharmacogenetic Marker, in Vietnamese Kinh People
Pham TTH, Tran QB, Sukasem C, Nguyen VD, Chu CH, Do TQN, Tran NPM, Phung TH
The Application of Clinical Genetics 2021, 14:27-35
Published Date: 9 February 2021
Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
Chamnanphon M, Gaedigk A, Puangpetch A, Pasomsub E, Chantratita W, Longley RJ, Sattabongkot J, Chariyavilaskul P, Sukasem C
Pharmacogenomics and Personalized Medicine 2020, 13:1-12
Published Date: 10 January 2020
Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia
Puangpetch A, Srisawasdi P, Unaharassamee W, Jiratjintana N, Vanavanan S, Punprasit S, Na Nakorn C, Sukasem C, Kroll MH
Pharmacogenomics and Personalized Medicine 2019, 12:155-166
Published Date: 6 August 2019
CYP2D6 polymorphisms and their influence on risperidone treatment
Puangpetch A, Vanwong N, Nuntamool N, Hongkaew Y, Chamnanphon M, Sukasem C
Pharmacogenomics and Personalized Medicine 2016, 9:131-147
Published Date: 1 December 2016
The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand
Bushyakanist A, Puangpetch A, Sukasem C, Kiertiburanakul S
Pharmacogenomics and Personalized Medicine 2015, 8:163-170
Published Date: 5 November 2015
A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study
Damronglerd P, Sukasem C, Thipmontree W, Puangpetch A, Kiertiburanakul S
Pharmacogenomics and Personalized Medicine 2015, 8:155-162
Published Date: 3 October 2015
Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
Hongkaew Y, Ngamsamut N, Puangpetch A, Vanwong N, Srisawasdi P, Chamnanphon M, Chamkrachchangpada B, Tan-kam T, Limsila P, Sukasem C
Neuropsychiatric Disease and Treatment 2015, 11:191-196
Published Date: 22 January 2015